6505--Melatonin Tablets Effective 09/15/26 - 09/14/27
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0015
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Melatonin Tablets. This contract, identified by procurement number 36E79726R0015, is set to be effective from September 15, 2026, through September 14, 2027. The primary objective of this procurement is to ensure a reliable supply of Melatonin Tablets for use within VA healthcare facilities, supporting the ongoing pharmaceutical needs of veterans under the department’s care.
The scope of this contract encompasses the manufacturing and delivery of Melatonin Tablets, classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505, which specifically pertains to drugs and biologicals. The selected contractor is expected to adhere to all applicable federal regulations and industry standards governing pharmaceutical preparation, ensuring that the delivered products meet the VA’s stringent quality and safety requirements.
Key deliverables under this contract include the timely and consistent provision of Melatonin Tablets in accordance with the VA’s specifications. The awarded supplier is responsible for maintaining product integrity throughout the contract period, with an emphasis on quality assurance, regulatory compliance, and reliable distribution to designated VA facilities.
The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this procurement is Deb Fassl, who can be reached via email at [email protected] or by phone at 708-786-5894 for any inquiries related to the contract or its administration.
This procurement is classified as an award notice, indicating that the contract has already been awarded and is currently active. Contractors interested in similar future opportunities should note that this procurement falls under the pharmaceutical manufacturing sector and is managed at the federal office level. No specific set-aside requirements or special considerations are indicated in the notice.
For further details or to review the official award documentation, interested parties may refer to the notice posted on SAM.gov using Opportunity ID eeac926ce1e7459db32d5c9adc610bc7 or visit the following URL: https://sam.gov/opp/eeac926ce1e7459db32d5c9adc610bc7/view.
This summary provides a comprehensive overview of the contract’s purpose, scope, and administrative details, offering essential context for contractors evaluating their alignment with similar federal pharmaceutical supply opportunities.